Director, Walther Cancer Research Center

navari

Education:
M.D., Medical College of Virginia
Ph.D., University of Virginia

Areas of Expertise: Supportive care in clinical oncology; Development of antiemetics; Palliative care; The doctor-patient relationship in clinical oncology

Recent Articles:
  • “The anti-ischemic agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice” (2004)
  • “A neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting” (2004)
  • “A phase II trial of olanzapine for the prevention of chemotherapy induced nausea and vomiting: A Hoosier Oncology Group study” (2005)
  • “Management of Nausea and Vomiting in Cancer Patients” (2005)
  • “Advances in the treatment of chemotherapy-induced nausea and vomiting” (2005)

Office: 100H Harper
Email: rnavari@nd.edu
Website: http://http://www.nd.edu/~transgen/biographies/adjunct_faculty/navari.html